Neridronic acid for treating complex regional pain syndrome
AssigneeAntecip Bioventures II LLC
InventorHerriot Tabuteau
Life of this patent
Estimating the term…
Abstract
Oral dosage forms of osteoclast inhibitors, such as neridronic acid, in an acid or a salt form, can be used to treat or alleviate pain or related conditions, such as complex regional pain syndrome.
Claims23
A method of treating complex regional pain syndrome (CRPS), comprising administering a parenteral dose of about 5 mg to about 200 mg of neridronic acid, in an acid form or a salt form, to a human being suffering from complex regional pain syndrome, wherein the human being has a pain score of at least about 4 on the 0-10 numeric rating scale (NRS) before the treatment, and wherein bone fracture was a predisposing event for CRPS.
Dependencies are inferred from the claim text.